Gravwell - Contact Us

Find out how you can own your orbit. TRANSFORMING HOW THE UNIVERSE DOES DATAIt’s all too easy to get sucked into broken models that limit what you can do with your data. Gravwell makes fusing massive data fast, simple, and unlimited, so good security teams can be even better. data aggregation platform, enterprise data fusion, analytics platform, orbit, empowers teams, gravwellhttps://www. io/

Can you tell us about your journey and what motivated you to co-found ForwardLane, particularly focusing on AI’s role in financial services? My journey into fintech came to me when I worked at the multi-asset alternative asset manager, CQS. There, we could find insights and act on them far ahead of financial institutions. When I saw how difficult it was for advisors to get to insights, I came up with the vision of an AI co-pilot for every financial advisor. Lastly, could you highlight any ongoing or upcoming projects or developments at ForwardLane that our audience should be excited about?

product_id=37144The automated data platform market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. Furthermore, this statistical market research repository examines and estimates the automated data platform market at the global and regional levels. product_id=37144Smart Home Market Geographical Segmentation Includes:·        North America (U. , Canada, and the Rest of North America)·        Europe (Germany, UK, Netherlands, France, Norway, Switzerland, Denmark, Rest of Europe)·        Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific) ·        Rest of the WorldNorth America dominated the automated data platform market in 2021 due to the increased demand for smart devices due to technological advancements and overall consumer awareness. Recent Developments:·        Scientists have developed an automated knowledge portal known as COVID Scholar that complies more than 260,000 research articles, patents, and clinical trials related to the coronavirus disease 2019 (COVID-19).